Related Experiment Video
Updated: Jun 29, 2025
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Milestone Operations in Heart Valve and Aortic Replacement: Anniversaries Worth Remembering
Uberto Bortolotti1, Igor Vendramin1, Aldo D Milano2
1Cardiothoracic Department, University Hospital, Udine, Italy.
Insights
Milestone events in aortic valve disease treatment from 1952 to 1982 are highlighted. These include early prostheses, homografts, and anticalcification treatments, showcasing significant advancements in cardiovascular surgery.
Area of Science:
- Cardiovascular Surgery
- Medical History
- Biomedical Engineering
Background:
- The clinical history of aortic and valvular diseases is marked by significant technological and procedural milestones.
- Understanding these advancements is crucial for appreciating the evolution of treatment strategies.
Purpose of the Study:
- To commemorate key historical events in the treatment of aortic and valvular diseases.
- To recognize the contributions of pioneers in cardiovascular surgery and medical innovation.
Main Methods:
- Historical review of seminal events in aortic valve disease treatment.
- Chronological recounting of significant surgical interventions and technological introductions.
Main Results:
- In 1952, the first caged-ball prosthesis was implanted for aortic valve insufficiency.
- In 1962, the first aortic homograft was implanted in a subcoronary position.
- In 1982, the first anticalcification treatment for porcine bioprostheses was introduced.
Conclusions:
- These historical events represent critical steps in the management of aortic and valvular diseases.
- The innovations discussed have profoundly influenced the clinical practice and outcomes for patients.
Abstract:
Seventy years ago, in 1952, Charles A. Hufnagel implanted a caged-ball prosthesis into the descending thoracic aorta, to treat a patient with aortic valve insufficiency. In 1962, 60 years ago, the first aortic homograft was implanted in a subcoronary position by Donald N. Ross and Brian G. Barratt-Boyes. Forty years ago, in 1982, the first anticalcification treatment was introduced in commercially manufactured porcine bioprostheses. All such important or even milestone events should be remembered, since they witness efforts made by those who have significantly influenced the clinical history of aortic and valvular diseases.
